A carregar...
Cost-effectiveness of screening for hepatitis C in Canada
BACKGROUND: The seroprevalence of hepatitis C virus (HCV) infection among Canadians is estimated at 0.3% to 0.9%. Of those with chronic HCV infection, 10% to 20% will experience advanced liver disease by 30 years of infection. Targeted screening seems a plausible strategy. We aimed to estimate the h...
Na minha lista:
| Publicado no: | CMAJ |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
8872147 Canada Inc.
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4330166/ https://ncbi.nlm.nih.gov/pubmed/25583667 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1503/cmaj.140711 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|